These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24474641)
1. Chromosome abnormalities in T-cell acute lymphoblastic leukemia in Korea. Park J; Kim M; Lee HK; Kim Y; Han K; Son J; Lee S; Chung NG; Cho B Int J Hematol; 2014 Mar; 99(3):279-87. PubMed ID: 24474641 [TBL] [Abstract][Full Text] [Related]
2. [Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol]. Liu XM; Chen XJ; Zou Y; Wang SC; Wang M; Zhang L; Chen YM; Yang WY; Guo Y; Zhu XF Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):761-766. PubMed ID: 31594062 [No Abstract] [Full Text] [Related]
3. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF; Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166 [TBL] [Abstract][Full Text] [Related]
4. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol. Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691 [TBL] [Abstract][Full Text] [Related]
6. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702 [TBL] [Abstract][Full Text] [Related]
7. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Matherly LH; Taub JW; Wong SC; Simpson PM; Ekizian R; Buck S; Williamson M; Amylon M; Pullen J; Camitta B; Ravindranath Y Blood; 1997 Jul; 90(2):578-89. PubMed ID: 9226157 [TBL] [Abstract][Full Text] [Related]
8. T-Cell Receptor Rearrangements Determined Using Fragment Analysis in Patients With T-Acute Lymphoblastic Leukemia. Kim H; Kim IS; Chang CL; Kong SY; Lim YT; Kong SG; Cho EH; Lee EY; Shin HJ; Park HJ; Eom HS; Lee H Ann Lab Med; 2019 Mar; 39(2):125-132. PubMed ID: 30430774 [TBL] [Abstract][Full Text] [Related]
10. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia. Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920 [TBL] [Abstract][Full Text] [Related]
11. [Long-term outcome of childhood T-cell acute lymphoblastic leukemia treated with modified national protocol of childhood leukemia in China-acute lymphoblastic leukemia 2008]. Liao C; Shen DY; Xu XJ; Xu WQ; Zhang JY; Song H; Yang SL; Zhao FY; Shen HP; Tang YM Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):758-763. PubMed ID: 32872717 [No Abstract] [Full Text] [Related]
12. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol]. Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010. Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia]. Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311 [TBL] [Abstract][Full Text] [Related]
16. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Wrzesień-Kuś A; Robak T; Pluta A; Zwolińska M; Wawrzyniak E; Wierzbowska A; Skotnicki A; Jakubas B; Hołowiecki J; Nowak K; Kuliczkowski K; Mazur G; Haus O; Dmoszyńska A; Adamczyk-Cioch M; Jedrzejczak WW; Paluszewska M; Konopka L; Pałynyczko G Ann Hematol; 2006 Jun; 85(6):366-73. PubMed ID: 16523310 [TBL] [Abstract][Full Text] [Related]
17. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol. Suzuki N; Yumura-Yagi K; Yoshida M; Hara J; Nishimura S; Kudoh T; Tawa A; Usami I; Tanizawa A; Hori H; Ito Y; Miyaji R; Oda M; Kato K; Hamamoto K; Osugi Y; Hashii Y; Nakahata T; Horibe K; Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250 [TBL] [Abstract][Full Text] [Related]
18. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475 [TBL] [Abstract][Full Text] [Related]
19. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Sakhdari A; Thakral B; Loghavi S; Kanagal-Shamanna R; Yin CC; Zuo Z; Routbort MJ; Luthra R; Medeiros LJ; Wang SA; Patel KP; Ok CY Cancer Med; 2020 Feb; 9(3):849-858. PubMed ID: 31804006 [TBL] [Abstract][Full Text] [Related]
20. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor. Short NJ; Kantarjian HM; Sasaki K; Ravandi F; Ko H; Cameron Yin C; Garcia-Manero G; Cortes JE; Garris R; O'Brien SM; Patel K; Khouri M; Thomas D; Jain N; Kadia TM; Daver NG; Benton CB; Issa GC; Konopleva M; Jabbour E Am J Hematol; 2017 Mar; 92(3):238-243. PubMed ID: 28006851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]